The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSA.L Regulatory News (SSA)

  • There is currently no data for SSA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sistema PJSFC: Binnopharm Group increases stake in Sintez to 88.6%

12 May 2021 08:00

Sistema PJSFC (SSA) Sistema PJSFC: Binnopharm Group increases stake in Sintez to 88.6% 12-May-2021 / 10:00 MSK Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


Binnopharm Group increases stake in Sintez to 88.6%

12 May 2021, Moscow - Sistema PJSFC ("Sistema", the "Corporation" or, together with its subsidiaries and affiliates, the "Group") (LSE: SSA, MOEX: AFKS), a publicly traded Russian investment company, announces that its fully owned subsidiary LLC Sistema Telecom Assets has contributed its 32.4% stake in OJSC Sintez to the authorised capital of LLC Binnopharm Group. Following the transaction, Binnopharm Group has increased its stake in OJSC Sintez to 88.6%.

As a result, the effective stake in Binnopharm Group owned by Sistema together with VTB, Sistema's financial partner in the development of the pharmaceuticals business, now stands at 86.5%. A consortium of investors consisting of the Russian Direct Investment Fund ("RDIF"), the Russia-China Investment Fund (co-founded by RDIF and China Investment Corporation) and leading Middle Eastern funds holds 12.5%, with the remaining 1% owned by a minority shareholder (an individual). 

Binnopharm Group is a full-cycle Russian pharmaceutical holding company that combines five production sites across Russia: JSC Alium (formerly OBL Pharm; Serpukhov district, Moscow region), JSC Binnopharm (two sites at Zelenograd and Krasnogorsk), JSC Sintez (Kurgan) and JSC Biocom (Stavropol). Binnopharm Group companies produce a wide range of drugs in various therapeutic groups and have the largest portfolio of drugs among Russian manufacturers with more than 450 marketing authorisations, including the COVID-19 vaccine Sputnik V.

***

For further information, please visit www.sistema.ru or contact:

Press Service of Sistema

Sergey Kopytov

Phone: +7 (495) 228 15 32

kopytov@sistema.ru

IR Service

Nikolai Minashin

Phone: +7 (495) 730 66 00

n.minashin@sistema.ru

 

Sistema PJSFC is a publicly traded Russian investment company with a diversified portfolio of assets serving over 150 million customers in the sectors of telecommunications, high technology, financial services, retail, paper and packaging, agriculture, real estate, tourism and medical services. The company was founded in 1993. Revenue in 2020 was RUB 691.6 billion; total assets equalled RUB 1.4 trillion as of 31 December 2020. Sistema's global depositary receipts are listed under the "SSA" ticker on the London Stock Exchange. Sistema's ordinary shares are listed under the "AFKS" ticker on the Moscow Exchange. Website: www.sistema.com.

 

 


ISIN:US48122U2042
Category Code:MSCH
TIDM:SSA
LEI Code:213800JSZ2UUK4QQK694
Sequence No.:104444
EQS News ID:1195434
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
30th Sep 201912:40 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
25th Sep 201911:00 amEQSSistema PJSFC: Sistema rating raised to ruA by Expert RA
23rd Sep 20195:30 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
17th Sep 20197:45 amEQSSistema PJSFC: Sistema launches RUB 3.0 billion share repurchase programme
30th Aug 201911:11 amEQSSistema PJSFC: Sistema credit rating raised to BB- by S&P
29th Aug 20198:11 amEQSSistema PJSFC: Sistema announces financial results for the second quarter 2019
12th Aug 20197:45 amEQSSistema PJSFC: Sistema to sell 49% of Leader Invest to Etalon Group
8th Aug 20197:50 amEQSSistema PJSFC: Sistema completes transaction to become shareholder of pharmaceutical businesses Sintez and Biocom
19th Jul 20193:15 pmEQSSistema PJSFC: Sistema closes order book on RUB 10 bn series 001Р-11 exchange-traded bonds
2nd Jul 20195:45 pmEQSSistema PJSFC: Changes in the shareholdings of members of the Board of Directors in Sistema PJSFC
1st Jul 20197:55 amEQSSistema PJSFC: Sistema announces results of AGM and Board of Directors meeting
25th Jun 20192:58 pmEQSSistema PJSFC: Report on Payments to Governments for 2018
17th Jun 20198:45 amEQSSistema PJSFC: Sistema attracts unsecured loan from VTB Bank (PJSC)
7th Jun 201910:38 amEQSSistema PJSFC: Sistema to acquire pharmaceutical companies Sintez and Biocom from Marathon Group
4th Jun 20198:01 amEQSSISTEMA ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER 2019
20th May 20198:00 amEQSSistema announces decisions of the Board of Directors
17th May 20193:00 pmEQSSistema PJSFC: Sistema redeems USD500 million Eurobond
6th May 20195:00 pmEQSSistema PJSFC: Information on a transaction under the MTS share buyback programme
29th Apr 20194:00 pmEQSSistema Annual Report 2018
29th Apr 20197:46 amEQSSistema PJSFC: Sistema increases its stake in Ozon
26th Apr 20198:05 amEQSSistema PJSFC: Correction: Sistema and VTB to create a major pharmaceuticals holding
26th Apr 20198:00 amEQSSistema PJSFC: RDIF, RCIF and Middle Eastern investors to acquire stake in OBL Pharm
3rd Apr 20195:00 pmEQSSistema PJSFC: Information on a transaction under the MTS share buyback programme
3rd Apr 20198:16 amEQSSISTEMA ANNOUNCES FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL YEAR 2018
1st Apr 20197:48 amEQSSistema announces decisions of the Board of Directors
28th Mar 20193:00 pmEQSSistema closes order book on RUB 10 bn series 001P-10 exchange-traded bonds
5th Mar 20194:00 pmEQSSistema PJSFC: Information on a transaction under the MTS share buyback programme
28th Feb 201912:03 pmEQSSistema PJSFC: Sistema closes order book on RUB 10 bn series 001P-09 exchange-traded bonds
21st Feb 20194:47 pmEQSSistema PJSFC: Acquisition of Sistema shares by Corporation employees
19th Feb 20194:45 pmEQSSistema acquires stake in Ozon from MTS
19th Feb 20194:00 pmEQSSistema becomes largest shareholder of Etalon Group
19th Feb 20194:00 pmRNSSistema Becomes Shareholder of Etalon Group
19th Feb 20197:00 amEQSSistema divests 51% stake in Leader Invest
12th Feb 20194:00 pmEQSSistema divests a stake in MTS Bank
6th Feb 20194:30 pmEQSSistema PJSFC: Sistema successfully completes secondary placement of series 001P-07 bonds
4th Feb 20194:00 pmEQSSistema PJSFC: Information on a transaction under the MTS share buyback programme
28th Dec 20186:55 amEQSSistema and VTB to create a major pharmaceuticals holding
14th Dec 20185:29 pmEQSChanges in the shareholdings of members of the Board of Directors in Sistema PJSFC
29th Nov 20185:20 pmRNSChanges in the shareholdings of members of the BoD
27th Nov 20187:06 amRNSSISTEMA ANNOUNCES FINANCIAL RESULTS FOR 3Q 2018
12th Nov 20184:00 pmEQSSistema PJSFC: Information on a transaction under the MTS share buyback programme
8th Oct 20183:10 pmRNSSistema rating raised to ruA- by Expert RA
3rd Oct 20185:00 pmRNSTransaction under the MTS share buyback programme
11th Sep 201811:30 amRNSAgreement with CapitalBio Technology and RCIF
10th Sep 20187:50 amRNSSistema announces decisions of Board of Directors
4th Sep 20185:00 pmRNSTransaction under the MTS share buyback programme
30th Aug 20188:00 amRNSFINANCIAL RESULTS FOR THE SECOND QUARTER 2018
23rd Aug 201810:40 amRNSSistema improves position in FTSE4Good index
7th Aug 20185:45 pmRNSTransaction under the MTS share buyback programme
30th Jul 201810:30 amRNSSistema secures credit facility from Otkritie Bank

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.